
CHROMOSOMAL ABNORMALITIES IN
ENDOMETRIAL AND OVARIAN CARCINOMAS PazarbaÕi A1,*, Kasap M1, Demirhan O1, Vardar MA2,
Suleymanova-Karahan D1, Doran F3 *Corresponding Author: *Corresponding Author: Ayfer PazarbaÕi, Ph.D., Department of Medical Biology and
Genetics, University of Çukurova, School of Medicine, 01330 Balcali, Adana, Turkey; Tel.:
+90-322-338-70-68; Fax: +90-322-338-65-72; E-mail: payfer@cu.edu.tr page: 61
|
MATERIALS AND METHODS
Freshly operated tumor samples were obtained from 38 patients who had undergone surgery for endometrial and ovarian carcinomas at the hospital section of the Obstetrics and Gynocology at the Medical School of Çuku rova University, Adana, Turkey. Fifteen were excluded from the study because of bacterial contamination, detachment, or presence of necrotic tissue, thus leaving 12 endo metrial and 11 ovarian tumors for study. All tissues were examined macroscopically at the Pathology Department, Medical School, Çukurova University, Adana, Turkey, and came from invasive epithelial tumors. The study was approved by the Ethical Boards of the Medical School.
The tissues were disaggregated in a solution of trypsin-EDTA. The cell lines were initiated in tissue culture flasks (25 cm2) in Chang complete medium supplemented with penicillin-streptomycin to establish primary cultures [9]. The flasks were harvested for cytogenetic analysis after 7 to 10 days by exposure to colcemid followed by hypotonic treatment and fixation in methanol: acetic acid (3:1). The slides were incubated at 37°C for 2 days. Chromosomal analyses from tissue cultures were performed according to standart cytogenetic methods using the Giemsa banding technique [10]. The GTG (G bands by trypsin using Giemsa) banded slides were used for cytogenetic analysis and karyotype descriptions were made according to the International System for Human Cytogenetic Nomenclature (ISCN) [11].
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|